The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
mTOR and cancer therapy
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
Datta, S. R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., & Greenberg, M. E. (1997) · Cell · doi:10.1016/s0092-8674(00)80405-5 · Cited by 5,689
Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., & Greenberg, M. E. (1999) · Cell · doi:10.1016/s0092-8674(00)80595-4 · Cited by 5,594
Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice
Lapidot, T., Sirard, C., Vormoor, J., Murdoch, B., Hoang, T., Caceres-Cortes, J., Minden, M., Paterson, B., Caligiuri, M. A., & Dick, J. E. (1994) · Nature · doi:10.1038/367645a0 · Cited by 4,783
TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival
Inoki, K., Zhu, T., & Guan, K.-L. (2003) · Cell · doi:10.1016/s0092-8674(03)00929-2 · Cited by 3,914
Levine, B., & Klionsky, D. J. (2004) · Developmental Cell · doi:10.1016/s1534-5807(04)00099-1 · Cited by 3,678
Bcl-2 Antiapoptotic Proteins Inhibit Beclin 1-Dependent Autophagy
Pattingre, S., Tassa, A., Qu, X., Garuti, R., Liang, X. H., Mizushima, N., Packer, M., Schneider, M. D., & Levine, B. (2005) · Cell · doi:10.1016/j.cell.2005.07.002 · Cited by 3,536
High Frequency of Mutations of the PIK3CA Gene in Human Cancers
Samuels, Y., Wang, Z., Bardelli, A., Silliman, N., Ptak, J., Szabo, S., Yan, H., Gazdar, A., Powell, S. M., Riggins, G. J., et al. (2004) · Science · doi:10.1126/science.1096502 · Cited by 3,437
Induction of autophagy and inhibition of tumorigenesis by beclin 1
Liang, X. H., Jackson, S., Seaman, M., Brown, K., Kempkes, B., Hibshoosh, H., & Levine, B. (1999) · Nature · doi:10.1038/45257 · Cited by 3,347
Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or Amplification
Gorre, M. E., Mohammed, M., Ellwood, K., Hsu, N., Paquette, R., Rao, P. N., & Sawyers, C. L. (2001) · Science · doi:10.1126/science.1062538 · Cited by 3,104
Steck, P. A., Pershouse, M. A., Jasser, S. A., Yung, W. K. A., Lin, H., Ligon, A. H., Langford, L. A., Baumgard, M. L., Hattier, T., Davis, T., et al. (1997) · Nature Genetics · doi:10.1038/ng0497-356 · Cited by 2,741
Zha, J., Harada, H., Yang, E., Jockel, J., & Korsmeyer, S. J. (1996) · Cell · doi:10.1016/s0092-8674(00)81382-3 · Cited by 2,595
mTOR Inhibition Induces Upstream Receptor Tyrosine Kinase Signaling and Activates Akt
O'Reilly, K. E., Rojo, F., She, Q.-B., Solit, D., Mills, G. B., Smith, D., Lane, H., Hofmann, F., Hicklin, D. J., Ludwig, D. L., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2925 · Cited by 2,561
Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB
Sarbassov, D. D., Ali, S. M., Sengupta, S., Sheen, J.-H., Hsu, P. P., Bagley, A. F., Markhard, A. L., & Sabatini, D. M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.03.029 · Cited by 2,365
Yue, Z., Jin, S., Yang, C., Levine, A. J., & Heintz, N. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2436255100 · Cited by 2,116
Lyden, D., Hattori, K., Dias, S., Costa, C., Blaikie, P., Butros, L., Chadburn, A., Heissig, B., Marks, W., Witte, L., et al. (2001) · Nature Medicine · doi:10.1038/nm1101-1194 · Cited by 1,860
Guba, M., von Breitenbuch, P., Steinbauer, M., Koehl, G., Flegel, S., Hornung, M., Bruns, C. J., Zuelke, C., Farkas, S., Anthuber, M., et al. (2002) · Nature Medicine · doi:10.1038/nm0202-128 · Cited by 1,739
Addiction to Oncogenes--the Achilles Heal of Cancer
Weinstein, I. B. (2002) · Science · doi:10.1126/science.1073096 · Cited by 1,728
Brugarolas, J., Lei, K., Hurley, R. L., Manning, B. D., Reiling, J. H., Hafen, E., Witters, L. A., Ellisen, L. W., & Kaelin, W. G. (2004) · Genes & Development · doi:10.1101/gad.1256804 · Cited by 1,384 · cited 1×
“Initial reports indicated that inhibition of mTOR under hypoxic conditions was the result of the HIF1 alpha-dependent transcript, REDD1, which functions in a TSC2-dependent manner (Brugarolas et al., 2004).”
BackgroundThe tor pathway: a target for cancer therapy
Bjornsti, M.-A., & Houghton, P. J. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1362 · Cited by 1,314
Self-citationTor, a Phosphatidylinositol Kinase Homologue, Controls Autophagy in Yeast
Noda, T., & Ohsumi, Y. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.7.3963 · Cited by 1,309
PIK3CA is implicated as an oncogene in ovarian cancer
Shayesteh, L., Lu, Y., Kuo, W.-L., Baldocchi, R., Godfrey, T., Collins, C., Pinkel, D., Powell, B., Mills, G. B., & Gray, J. W. (1999) · Nature Genetics · doi:10.1038/5042 · Cited by 1,155
Protection against Fatal Sindbis Virus Encephalitis by Beclin, a Novel Bcl-2-Interacting Protein
Liang, X. H., Kleeman, L. K., Jiang, H. H., Gordon, G., Goldman, J. E., Berry, G., Herman, B., & Levine, B. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.8586-8596.1998 · Cited by 1,132
Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells
Yilmaz, Ö. H., Valdez, R., Theisen, B. K., Guo, W., Ferguson, D. O., Wu, H., & Morrison, S. J. (2006) · Nature · doi:10.1038/nature04703 · Cited by 1,113
The LKB1 tumor suppressor negatively regulates mTOR signaling
Shaw, R. J., Bardeesy, N., Manning, B. D., Lopez, L., Kosmatka, M., DePinho, R. A., & Cantley, L. C. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.007 · Cited by 1,077
Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells
Kanzawa, T., Germano, I. M., Komata, T., Ito, H., Kondo, Y., & Kondo, S. (2004) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401359 · Cited by 986
Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR
Neshat, M. S., Mellinghoff, I. K., Tran, C., Stiles, B., Thomas, G., Petersen, R., Frost, P., Gibbons, J. J., Wu, H., & Sawyers, C. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171076798 · Cited by 969
Majumder, P. K., Febbo, P. G., Bikoff, R., Berger, R., Xue, Q., McMahon, L. M., Manola, J., Brugarolas, J., McDonnell, T. J., Golub, T. R., et al. (2004) · Nature Medicine · doi:10.1038/nm1052 · Cited by 964
A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles.
Paglin, S., Hollister, T. C., Delohery, T. M., Hackett, N., McMahill, M., Sphicas, E., Domingo, D., & Yahalom, J. (2001) · PubMed · Cited by 952
Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy
Wendel, H.-G., Stanchina, E. D., Fridman, J. S., Malina, A., Ray, S., Kogan, S., Cordon-Cardo, C., Pelletier, J., & Lowe, S. W. (2004) · Nature · doi:10.1038/nature02369 · Cited by 951
Role of VHL Gene Mutation in Human Cancer
Kim, W. Y., & Kaelin, W. G. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.061 · Cited by 943
Atkins, M. B., Hidalgo, M., Stadler, W. M., Logan, T. F., Dutcher, J. P., Hudes, G. R., Park, Y., Liou, S.-H., Marshall, B., Boni, J. P., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.185 · Cited by 942
Structure of the FKBP12-Rapamycin Complex Interacting with Binding Domain of Human FRAP
Choi, J., Chen, J., Schreiber, S. L., & Clardy, J. (1996) · Science · doi:10.1126/science.273.5272.239 · Cited by 929
Nourse, J., Firpo, E., Flanagan, W. M., Coats, S., Polyak, K., Lee, M.-H., Massague, J., Crabtree, G. R., & Roberts, J. M. (1994) · Nature · doi:10.1038/372570a0 · Cited by 889
Increased Risk of Cancer in the Peutz–Jeghers Syndrome
Giardiello, F. M., Welsh, S. B., Hamilton, S. R., Offerhaus, G. J. A., Gittelsohn, A. M., Booker, S. V., Krush, A. J., Yardley, J. H., & Luk, G. D. (1987) · New England Journal of Medicine · doi:10.1056/nejm198706113162404 · Cited by 848
Hypoxia-induced energy stress regulates mRNA translation and cell growth
Liu, L., Cash, T. P., Jones, R. G., Keith, B., Thompson, C. B., & Simon, M. C. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.01.010 · Cited by 607
Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer
Thomas, G. V., Tran, C., Mellinghoff, I. K., Welsbie, D. S., Chan, E., Fueger, B., Czernin, J., & Sawyers, C. L. (2006) · Nature Medicine · doi:10.1038/nm1337 · Cited by 604
The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis
Ruggero, D., Montanaro, L., Ma, L., Xu, W., Londei, P., Cordon-Cardo, C., & Pandolfi, P. P. (2004) · Nature Medicine · doi:10.1038/nm1042 · Cited by 586
An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten+/−mice
Podsypanina, K., Lee, R. T., Politis, C., Hennessy, I., Crane, A., Puc, J., Neshat, M., Wang, H., Yang, L., Gibbons, J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171060098 · Cited by 569
Treins, C., Giorgetti-Peraldi, S., Murdaca, J., Semenza, G. L., & Van Obberghen, E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204152200 · Cited by 539
Bursch, W., Ellinger, A., Kienzl, H., Török, L., Pandey, S., Sikorska, M., Walker, R., & Hermann, R. S. (1996) · Carcinogenesis · doi:10.1093/carcin/17.8.1595 · Cited by 516
Phase II Trial of Single-Agent Temsirolimus (CCI-779) for Relapsed Mantle Cell Lymphoma
Witzig, T. E., Geyer, S. M., Ghobrial, I., Inwards, D. J., Fonseca, R., Kurtin, P., Ansell, S. M., Luyun, R., Flynn, P. J., Morton, R. F., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.13.466 · Cited by 514
PTEN/MMAC1 mutations in endometrial cancers.
Risinger, J. I., Hayes, A. K., Berchuck, A., & Barrett, J. C. (1997) · PubMed · Cited by 506
Chan, S., Scheulen, M. E., Johnston, S., Mross, K., Cardoso, F., Dittrich, C., Eiermann, W., Hess, D., Morant, R., Semiglazov, V., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.66.130 · Cited by 468
Arsham, A. M., Howell, J. J., & Simon, M. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212770200 · Cited by 463 · cited 2×
“If cells in culture are exposed to hypoxic conditions, mTOR activity is rapidly inhibited, as measured by both autophosphorylation of mTOR, and phosphorylation of the mTOR substrates S6K1 and 4EBP1 (Arsham et al., 2003).”
BackgrounddeGraffenried, L. A., Friedrichs, W. E., Russell, D. H., Donzis, E. J., Middleton, A. K., Silva, J. M., Roth, R. A., & Hidalgo, M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0035 · Cited by 387
Tuberous Sclerosis: from Tubers to mTOR
Kwiatkowski, D. J. (2003) · Annals of Human Genetics · doi:10.1046/j.1469-1809.2003.00012.x · Cited by 339
Yeung, R. S., Xiao, G. H., Jin, F., Lee, W. C., Testa, J. R., & Knudson, A. G. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.24.11413 · Cited by 307
Lieberthal, W., Fuhro, R., Andry, C. C., Rennke, H., Abernathy, V. E., Koh, J. S., Valeri, R., & Levine, J. S. (2001) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2001.281.4.f693 · Cited by 270
Mohi, M. G., Boulton, C., Gu, T.-L., Sternberg, D. W., Neuberg, D., Griffin, J. D., Gilliland, D. G., & Neel, B. G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400063101 · Cited by 239
Paglin, S., Lee, N.-Y., Nakar, C., Fitzgerald, M., Plotkin, J., Deuel, B., Hackett, N., McMahill, M., Sphicas, E., Lampen, N., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1083 · Cited by 220
Connolly, E., Braunstein, S., Formenti, S., & Schneider, R. J. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.10.3955-3965.2006 · Cited by 219
c-Myc Protein Synthesis Is Initiated from the Internal Ribosome Entry Segment during Apoptosis
Stoneley, M., Chappell, S. A., Jopling, C. L., Dickens, M., MacFarlane, M., & Willis, A. E. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.4.1162-1169.2000 · Cited by 219
Huang, S., Shu, L., Dilling, M. B., Easton, J., Harwood, F. C., Ichijo, H., & Houghton, P. J. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00180-1 · Cited by 216
Self-citationShantz, L. M., & Pegg, A. E. (1994) · PubMed · Cited by 208
PIK3CA mutations in breast cancer are associated with poor outcome
Li, S. Y., Rong, M., Grieu, F., & Iacopetta, B. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-9048-0 · Cited by 207
Combination of the mTOR inhibitor rapamycin and CC-5013 has synergistic activity in multiple myeloma
Raje, N., Kumar, S., Hideshima, T., Ishitsuka, K., Chauhan, D., Mitsiades, C., Podar, K., Le Gouill, S., Richardson, P., Munshi, N. C., et al. (2004) · Blood · doi:10.1182/blood-2004-06-2281 · Cited by 187
Enhanced radiation damage of tumor vasculature by mTOR inhibitors
Shinohara, E. T., Cao, C., Niermann, K., Mu, Y., Zeng, F., Hallahan, D. E., & Lu, B. (2005) · Oncogene · doi:10.1038/sj.onc.1208715 · Cited by 183
Rosenwald, I. B., Chen, J.-J., Wang, S., Savas, L., London, I. M., & Pullman, J. (1999) · Oncogene · doi:10.1038/sj.onc.1202563 · Cited by 174
Barata, J. T., Cardoso, A. A., Nadler, L. M., & Boussiotis, V. A. (2001) · Blood · doi:10.1182/blood.v98.5.1524 · Cited by 173
FRAP/mTOR is required for proliferation and patterning during embryonic development in the mouse
Hentges, K. E., Sirry, B., Gingeras, A.-C., Sarbassov, D., Sonenberg, N., Sabatini, D., & Peterson, A. S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241184198 · Cited by 171
Shi, Y., Sharma, A., Wu, H., Lichtenstein, A. K., & Gera, J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m407874200 · Cited by 165
Huang, S., Liu, L. N., Hosoi, H., Dilling, M. B., Shikata, T., & Houghton, P. J. (2001) · PubMed · Cited by 163
Self-citationWoltman, A. M., van der Kooij, S. W., Coffer, P. J., Offringa, R., Daha, M. R., & van Kooten, C. (2003) · Blood · doi:10.1182/blood-2002-06-1688 · Cited by 153
Edwards, E., Geng, L., Tan, J., Onishko, H. M., Donnelly, E. F., & Hallahan, D. E. (2002) · PubMed · Cited by 152
Elongation Factor-2 Kinase Regulates Autophagy in Human Glioblastoma Cells
Wu, H., Yang, J., Jin, S., Zhang, H., & Hait, W. N. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1554 · Cited by 148
CREW, J. P., Fuggle, S., Bicknell, R., Cranston, D., Benedetti, A. D., & Harris, A. L. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.0894 · Cited by 138
Scott, P., Smith, K. J., Poulsom, R., Benedetti, A. D., Bicknell, R., & Harris, A. L. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.356 · Cited by 117
Identification of N10-Substituted Phenoxazines as Potent and Specific Inhibitors of Akt Signaling
Thimmaiah, K. N., Easton, J. B., Germain, G. S., Morton, C. L., Kamath, S., Buolamwini, J. K., & Houghton, P. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507057200 · Cited by 113
Self-citationSecombe, J., Pierce, S. B., & Eisenman, R. N. (2004) · Cell · doi:10.1016/s0092-8674(04)00336-8 · Cited by 109
Yan, H., Frost, P., Shi, Y., Hoang, B. Q., Sharma, S., Fisher, M., Gera, J., & Lichtenstein, A. K. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2447 · Cited by 107
Expression of the translation initiation factor eIF4E in the polyp-cancer sequence in the colon.
Berkel, H. J., Turbat‐Herrera, E. A., Shi, R., & Benedetti, A. D. (2001) · PubMed · Cited by 106
Couch, F. J., Wang, X. Y., Wu, G., Qian, J., Jenkins, R. B., & James, C. D. (1999) · PubMed · Cited by 99
Law, B. K., Chytil, A., Dumont, N., Hamilton, E. G., Waltner-Law, M. E., Aakre, M. E., Covington, C. D., & Moses, H. L. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.23.8184-8198.2002 · Cited by 99
Dilling, M. B., Germain, G. S., Dudkin, L., Jayaraman, A. L., Zhang, X., Harwood, F. C., & Houghton, P. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110782200 · Cited by 98
Self-citationProspective Study of Eukaryotic Initiation Factor 4E Protein Elevation and Breast Cancer Outcome
Li, B. D. �., Gruner, J. S., Abreo, F. W., Johnson, L. W., Yu, H., Nawas, S., McDonald, J. C., & Benedetti, A. D. (2002) · Annals of Surgery · doi:10.1097/00000658-200205000-00016 · Cited by 87
Clinical development of mammalian target of rapamycin inhibitors
Dancey, J. E. (2002) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(02)00051-5 · Cited by 81
Bader, A. G., Felts, K. A., Jiang, N., Chang, H. W., & Vogt, P. K. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2135336100 · Cited by 80
Profiling of Protein Kinases in the Neoplastic Transformation of Human Ovarian Surface Epithelium
Wong, A. S. T., Kim, S. O., Leung, P. C. K., Auersperg, N., & Pelech, S. (2001) · Gynecologic Oncology · doi:10.1006/gyno.2001.6280 · Cited by 76
Rosenwald, I. B. (1996) · Cancer Letters · doi:10.1016/0304-3835(96)04171-7 · Cited by 66
Gemmill, R. M., Zhou, M., Costa, L. J., Korch, C. T., Bukowski, R. M., & Drabkin, H. A. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602646 · Cited by 54
Wang, S., Lloyd, R. V., Hutzler, M., Rosenwald, I. B., Safran, M., Patwardhan, N. A., & Khan, A. A. (2001) · Thyroid · doi:10.1089/10507250152740939 · Cited by 52
Sorrells, D. L., Meschonat, C., Black, D. R., & Li, B. D. �. (1999) · Journal of Surgical Research · doi:10.1006/jsre.1999.5653 · Cited by 48
Haydon, M. S., Googe, J. D., Sorrells, D. S., Ghali, G. E., & Li, B. D. �. (2000) · Cancer · doi:10.1002/1097-0142(20000615)88:12<2803::aid-cncr20>3.0.co;2-5 · Cited by 43
Suppression of PI3K/mTOR pathway rescues LLC cells from cell death induced by hypoxia
Hamanaka, Y., Mukai, M., Shimamura, M. I., Kitagawa, T., Nishida, T., Isohashi, F., Ito, T., Nishizawa, Y., Tatsuta, M., Matsuda, H., et al. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.02.163 · Cited by 24
Cited by
Defining the role of mTOR in cancer
Guertin, D. A., & Sabatini, D. M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.05.008 · Cited by 2,833
Targeting PI3K signalling in cancer: opportunities, challenges and limitations
Engelman, J. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2664 · Cited by 2,445
Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outputs of mTORC1 and mTORC2
Feldman, M. E., Apsel, B., Uotila, A., Loewith, R., Knight, Z. A., Ruggero, D., & Shokat, K. M. (2009) · PLoS Biology · doi:10.1371/journal.pbio.1000038 · Cited by 1,082
Everolimus for Subependymal Giant-Cell Astrocytomas in Tuberous Sclerosis
Krueger, D. A., Care, M. M., Holland, K., Agricola, K., Tudor, C., Mangeshkar, P., Wilson, K. A., Byars, A., Sahmoud, T., & Franz, D. N. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001671 · Cited by 1,006
Effects of Aneuploidy on Cellular Physiology and Cell Division in Haploid Yeast
Torres, E. M., Sokolsky, T., Tucker, C. M., Chan, L. Y., Boselli, M., Dunham, M. J., & Amon, A. (2007) · Science · doi:10.1126/science.1142210 · Cited by 935
Metadata
- Authors
- Easton, J. B., & Houghton, P. J.
- Venue
- Oncogene
- Published
- 2006-10-16
- Volume
- 25
- Issue
- 48
- Pages
- 6436-6446
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W1988184140
- Cited by
- 459
- References
- 86
- FWCI
- 17.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.